83 research outputs found
Recommended from our members
SLC19A1 transports immunoreactive cyclic dinucleotides.
The accumulation of DNA in the cytosol serves as a key immunostimulatory signal associated with infections, cancer and genomic damage1,2. Cytosolic DNA triggers immune responses by activating the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway3. The binding of DNA to cGAS activates its enzymatic activity, leading to the synthesis of a second messenger, cyclic guanosine monophosphate-adenosine monophosphate (2'3'-cGAMP)4-7. This cyclic dinucleotide (CDN) activates STING8, which in turn activates the transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), promoting the transcription of genes encoding type I interferons and other cytokines and mediators that stimulate a broader immune response. Exogenous 2'3'-cGAMP produced by malignant cells9 and other CDNs, including those produced by bacteria10-12 and synthetic CDNs used in cancer immunotherapy13,14, must traverse the cell membrane to activate STING in target cells. How these charged CDNs pass through the lipid bilayer is unknown. Here we used a genome-wide CRISPR-interference screen to identify the reduced folate carrier SLC19A1, a folate-organic phosphate antiporter, as the major transporter of CDNs. Depleting SLC19A1 in human cells inhibits CDN uptake and functional responses, and overexpressing SLC19A1 increases both uptake and functional responses. In human cell lines and primary cells ex vivo, CDN uptake is inhibited by folates as well as two medications approved for treatment of inflammatory diseases, sulfasalazine and the antifolate methotrexate. The identification of SLC19A1 as the major transporter of CDNs into cells has implications for the immunotherapeutic treatment of cancer13, host responsiveness to CDN-producing pathogenic microorganisms11 and-potentially-for some inflammatory diseases
Attributing scientific and technical progress: the case of holography
Holography, the three-dimensional imaging technology, was portrayed widely as a paradigm
of progress during its decade of explosive expansion 1964–73, and during its subsequent
consolidation for commercial and artistic uses up to the mid 1980s. An unusually
seductive and prolific subject, holography successively spawned scientific insights, putative
applications and new constituencies of practitioners and consumers. Waves of forecasts,
associated with different sponsors and user communities, cast holography as a field on the
verge of success—but with the dimensions of success repeatedly refashioned. This retargeting
of the subject represented a degree of cynical marketeering, but was underpinned by
implicit confidence in philosophical positivism and faith in technological progressivism.
Each of its communities defined success in terms of expansion, and anticipated continual
progressive increase. This paper discusses the contrasting definitions of progress in holography,
and how they were fashioned in changing contexts. Focusing equally on reputed ‘failures’ of some aspects of the subject, it explores the varied attributes by which success and failure were linked with progress by different technical communities. This important case illuminates the peculiar post-World War II environment that melded the military, commercial and popular engagement with scientific and technological subjects, and the
competing criteria by which they assessed the products of science
Estimated Ultraviolet Radiation Doses in Wetlands in Six National Parks
Ultraviolet-B radiation (UV-B, 280–320-nm wavelengths) doses were estimated for 1024 wetlands in six national parks: Acadia (Acadia), Glacier (Glacier), Great Smoky Mountains (Smoky), Olympic (Olympic), Rocky Mountain (Rocky), and Sequoia/ Kings Canyon (Sequoia). Estimates were made using ground-based UV-B data (Brewer spectrophotometers), solar radiation models, GIS tools, field characterization of vegetative features, and quantification of DOC concentration and spectral absorbance. UV-B dose estimates were made for the summer solstice, at a depth of 1 cm in each wetland. The mean dose across all wetlands and parks was 19.3 W-h m-2 (range of 3.4–32.1 W-h m-2). The mean dose was lowest in Acadia (13.7 W-h m-2) and highest in Rocky (24.4 W-h m-2). Doses were significantly different among all parks. These wetland doses correspond to UV-B flux of 125.0 µW cm-2 (range 21.4–194.7 µW cm)2) based on a day length, averaged among all parks, of 15.5 h. Dissolved organic carbon (DOC), a key determinant of water-column UV-B flux, ranged from 0.6 (analytical detection limit) to 36.7 mg C L-1 over all wetlands and parks, and reduced potential maximal UV-B doses at 1-cm depth by 1%–87 %. DOC concentration, as well as its effect on dose, was lowest in Sequoia and highest in Acadia (DOC was equivalent in Acadia, Glacier, and Rocky). Landscape reduction of potential maximal UV-B doses ranged from zero to 77% and was lowest in Sequoia. These regional differences in UV-B wetland dose illustrate the importance of considering all aspects of exposure in evaluating the potential impact of UV-B on aquatic organisms
User-made immobilities: a transitions perspective
In this paper we aim to conceptualize the role of users in creating, expanding and stabilizing the automobility system. Drawing on transition studies we offer a typology of user roles including user-producers, user-legitimators, user-intermediaries, user-citizens and user-consumers, and explore it on the historical transition to the automobile regime in the USA. We find that users play an important role during the entire transition process, but some roles are more salient than others in particular phases. Another finding is that the success of the transition depends on the stabilization of the emerging regime that will trigger upscaling in terms of the numbers of adopters. The findings are used to reflect on potential crossovers between transitions and mobilities research
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Evolving treatments, disease phenotypes, and biology, together with a changing drug development environment, have created the need to revise castration-resistant prostate cancer (CRPC) clinical trial recommendations to succeed those from prior Prostate Cancer Clinical Trials Working Groups
RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite
Macromolecular modeling and design are increasingly useful in basic research, biotechnology, and teaching. However, the absence of a user-friendly modeling framework that provides access to a wide range of modeling capabilities is hampering the wider adoption of computational methods by non-experts. RosettaScripts is an XML-like language for specifying modeling tasks in the Rosetta framework. RosettaScripts provides access to protocol-level functionalities, such as rigid-body docking and sequence redesign, and allows fast testing and deployment of complex protocols without need for modifying or recompiling the underlying C++ code. We illustrate these capabilities with RosettaScripts protocols for the stabilization of proteins, the generation of computationally constrained libraries for experimental selection of higher-affinity binding proteins, loop remodeling, small-molecule ligand docking, design of ligand-binding proteins, and specificity redesign in DNA-binding proteins
Cabozantinib in Chemotherapy-Pretreated Metastatic Castration-Resistant Prostate Cancer: Results of a Phase II Nonrandomized Expansion Study
Cabozantinib (XL184), an oral inhibitor of multiple receptor tyrosine kinases such as MET and VEGFR2, was evaluated in a phase II nonrandomized expansion study in castration-resistant prostate cancer (CRPC)
The Effect of Fasting on PET Imaging of Hepatocellular Carcinoma
La steppe en Algérie est un espace stratégique en matière de lutte contre la désertification, il couvre plus de 20 millions d’hectares et connaît une dégradation importante. Différents programmes de protection et de réhabilitation de cet espace ont échoué et sont souvent à l’origine de l’aggravation de cette dégradation. Une synthèse sur les causes de cet échec permettront de proposer une nouvelle approche axée sur l’introduction d’une espèce végétale très rustique et dont l’impact écologique pourrait sauver la steppe.The steppe in Algeria is a strategic space as regards to the control of desertification, it covers more than 20 million hectares and knows an important degradation. Various programmes of protection and rehabilitation concerning this space failed and are at the origin of the aggravation of this degradation. A synthesis of the causes of this failure will make it possible to propose a new approach centered on the introduction of a very rustic plant species and whose ecological impact could save the steppe
Current Issues of Cybersecurity
Panelists:
Mr. Paul Rozenzweig, founder of Red Branch Consulting PLLC, and former Deputy Assistant Secretary for Policy, and also the former Acting Assistant Secretary for International Affairs, in the Department of Homeland Security; Senior Fellow, R Street Institute, Washington, D.C.
Prof. Gary Corn, Colonel, USA (Ret.). former staff judge advocate (General Counsel) of U.S. Cyber Command, currently Director of the Tech, Law & Security Program at American University\u27s Washington College of Law; Senior Fellow in Cybersecurity & Emerging Threats at the R Street Institute, Washington, D.C.
Prof. David Hoffman, Duke University Sanford School of Public Policy and Associate General Counsel at Intel Corporation
Moderator: Maj. Gen. Charlie Dunlap, USAF (Ret.), LENS Executive Director, Duke Law Schoo
Imaging Unique DNA Sequences in Individual Cells Using a CRISPR-Cas9-Based, Split Luciferase Biosensor
An extensive arsenal of biosensing tools has been developed based on the clustered regularly interspaced short palindromic repeat (CRISPR) platform, including those that detect specific DNA sequences both in vitro and in live cells. To date, DNA imaging approaches have traditionally used full fluorescent reporter-based fusion probes. Such “always-on” probes differentiate poorly between bound and unbound probe and are unable to sensitively detect unique copies of a target sequence in individual cells. Herein we describe a DNA biosensor that provides a sensitive readout for such low-copy DNA sequences through proximity-mediated reassembly of two independently optimized fragments of NanoLuc luciferase (NLuc), a small, bright luminescent reporter. Applying this “turn-on” probe in live cells, we demonstrate an application not easily achieved by fluorescent reporter-based probes, detection of individual endogenous genomic loci using standard epifluorescence microscopy. This approach could enable detection of gene edits during ex vivo editing procedures and should be a useful platform for many other live cell DNA biosensing applications
- …